the ema perspective: rapid clinical research approval & interpretation data during covid-19 pandemic
Published 4 years ago • 368 plays • Length 30:49Download video MP4
Download video MP3
Similar videos
-
18:42
covid-19: current treatment and ongoing trials
-
14:18
interpreting meta-analyses and clinical trials: can we believe the data? - g. savarese
-
52:06
designing clinical trials during a pandemic: some personal lessons from covid-19
-
56:13
covid-19 product development & clinical trials: considerations from european regulatory perspectives
-
12:50
minimize the impact of covid-19 on your clinical trials
-
56:01
clinical trials and covid-19: shaping of agenda, policies and practices for a transparent future
-
3:47
orange county covid-19 cases city-by-city data interpretation by dr. yang - mar 28th, 2020
-
1:04:01
clinical trials at the time of covid-19: and beyond?
-
0:15
day in a life of a clinical research associate ✨
-
1:10:22
examples from clinical trials - s. wassmann
-
2:58:22
reimagining clinical trials: learning from covid-19, second meeting 6/24/2021
-
13:19
clinical trials in times of corona - fda and ema update
-
31:51
planning & running a clinical trial: site perspective - b.s. lewis
-
37:30
how to interpret clinical trial data – examples from recent clinical trials
-
1:25:09
adjusting non-covid-19 clinical trials in the era of the pandemic: statistical design and analysis
-
1:42:25
5 - learning rapidly to improve the conduct of cancer clinical research beyond the covid-19 pandemic
-
53:38
lesson 7 | covid-19 clinical research and clinical trials
-
1:25:34
impact of covid-19 on the future of clinical trials
-
1:25:54
covid-19: a clinical research perspective